Methods and means for metabolic engineering and improved product formation by micro-organisms

US9834773B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9834773-B2
Application numberUS-22405007-A
CountryUS
Kind codeB2
Filing dateFeb 14, 2007
Priority dateFeb 14, 2006
Publication dateDec 5, 2017
Grant dateDec 5, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described are methods and means for metabolic engineering and improved product formation by a filamentous micro-organism or a low G+C gram-positive bacterium. Disclosed is that DasR and DasR binding sites play an important and universal role in the control of gene expression in micro-organisms. Based on this finding, provided are multiple useful applications, such as a method for regulating the expression of a gene of interest, a method for controlling metabolism, a method for decreasing undesired expression and many more. Moreover, provided are means that can be used to establish said methods: for example a micro-organism in which the DasR binding site in operable linkage with a particular gene has been modified to obtain increased or decreased expression of a protein (being a desired or undesired protein) encoded by said gene.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for regulating expression of a gene of interest in a micro-organism comprising a DasR protein, wherein the gene of interest is in operable linkage to a DasR-binding site, the method comprising: providing the micro-organism with a compound selected from the group consisting of glucosamine-6-phosphate, N-acetylglucosamine-6-phosphate, N-acetylglucosamine, and multimers thereof, such that the expression of the gene of interest is regulated; screening for the production of a secondary metabolite; and wherein the DasR-binding site is selected from the group consisting of: NN(T/A)GG(T/A)(C/G)T(A/G)N(A/T)C(C/A)(A/C)N(SEQ ID NO:1); (A/G)N(T/A)(G/T)(G/A)T(C/A)TA(G/T)A(C/T)(C/A)(A/T)N(T/C) (SEQ ID NO: 4); A(T/A)(T/C)(G/A)(G/A)TATATA(C/T)(C/T)(A/G)(A/T)T (SEQ ID NO: 5); A(T/C)(T/C)(G/T)(G/A)T(A/C)TA(T/G)A(C/T)(C/A)(A/G)(A/G)T (SEQ ID NO: 6); and (A/T)(T/A)T(G/A)(G/T)(A/C)TA(T/G)N(C/A)(C/T)A(A/T)(T/A) (SEQ ID NO: 7). 2. The method according to claim 1 wherein the compound is selected from the group consisting of glucosamine-6-phosphate, N-acetylglucosamine, and multimers thereof. 3. The method according to claim 1 , further comprising providing the micro-organism with a polynucleotide encoding a DasR protein. 4. The method according to claim 1 , wherein the microorganism is a Streptomyces , a Nocardia , a Thermobifido , an Amycolatopsis , a Planobispora , a Streptoverticillium , a Rhodococcus , or a Corynebacterium. 5. The method according to claim 1 , wherein the micro-organism is a low G+C gram-positive bacterium. 6. The method according to claim 1 , further comprising introducing into the micro-organism the DasR-binding site in operable linkage with the gene of interest. 7. The method according to claim 1 , wherein the micro-organism is a Streptomyces , a Nocardia , a Thermobifido , a Amycolatopsis , a Planobispora , a Streptoverticillium , a Rhodococcus , a Corynebacterium , or a low G+C gram-positive bacterium. 8. The method according to claim 1 , further comprising purifying the secondary metabolite.

Assignees

Inventors

Classifications

  • from Actinomyces; from Streptomyces (G) · CPC title

  • Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound (C12N1/34 takes precedence) · CPC title

  • C12N15/52Primary

    Genes encoding for enzymes or proenzymes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9834773B2 cover?
Described are methods and means for metabolic engineering and improved product formation by a filamentous micro-organism or a low G+C gram-positive bacterium. Disclosed is that DasR and DasR binding sites play an important and universal role in the control of gene expression in micro-organisms. Based on this finding, provided are multiple useful applications, such as a method for regulating the…
Who is the assignee on this patent?
Rigali Sebastien, Titgemeyer Mannfred Friedrich Bruno, Van Wezel Gilles Philippus, and 3 more
What technology area does this patent fall under?
Primary CPC classification C12N15/52. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).